<- Go Home

Athersys, Inc.

Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine.

Market Cap

$61.00

Volume

405.8K

Cash and Equivalents

$1.0M

EBITDA

-$28.2M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

-$18.7M

Profit Margin

-23368.75%

52 Week High

$0.04

52 Week Low

$0.00

Dividend

N/A

Price / Book Value

0.00

Price / Earnings

0.00

Price / Tangible Book Value

0.00

Enterprise Value

$17.6M

Enterprise Value / EBITDA

-0.69

Operating Income

-$28.7M

Return on Equity

141.51%

Return on Assets

-83.56

Cash and Short Term Investments

$1.0M

Debt

$18.6M

Equity

-$36.4M

Revenue

$80.0K

Unlevered FCF

-$25.1M

Sector

Biotechnology

Category

N/A

Company Stock Pitches